… -on-pharmaceuticals-market-102685 Pharmaceuticals Market … for pharmaceutical products. Growing healthcare expenditure, strong … agreements among pharmaceutical companies are … Pharmaceuticals Market Segmentation Analysis The pharmaceuticals …

… . Per capita healthcare expenditure in Bangladesh almost doubled … company. "The drug maker continues to grow in … Management, said leading drug makers posted steady profit growth … Sina Pharma posted the highest increase in profit among drug makers, …

… Trent, BPCL, Bajaj Finance, Mankind Pharma, Apollo Tyres among others will … (BPCL) has raised its capital expenditure plan for the coming fiscal … of the company. Mankind Pharma Indian drugmaker Mankind Pharma reported a higher ‍third …

Common drugs, foods, and beverages can disrupt the integrity of our intestinal barrier, causing a leaky gut. Intestinal permeability, the leakiness of our gut, may be a new target for both disease prevention and therapy. With all its tiny folds, our …

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) … non-GAAP SG&A expenditure between $2.5 billion … Officer of Regeneron. Regeneron Pharmaceuticals shares gained 2.1% … their price targets on Regeneron Pharmaceuticals following earnings announcement. Considering …

… rate of 10%. Capital expenditure has been increased by … fiscal year. Effective capital expenditure, which includes grants for … biologics‑focused incentives.  Sun Pharma — Large‑cap proxy for … biologics/complex pharma as domestic capability scales. …

… would roughly double its capital expenditure in 2025. The company’s … 3% in after-hours trading. Drug maker Novo Nordisk’s shares plummeted … , Brazil and Canada. The Danish pharmaceutical company's chief executive …

… rebates payable by pharmaceutical companies for the … the following United States Pharmacopeia (USP) drug classification … have the highest Medicare expenditures and where “access … for many pharmaceutical initiatives and limit drug company investments for …

… benefits. Since September,16 major drug companies have done deals with the … of year when pharmaceutical companies roll out price hikes, drug companies, including all … and (b) its total annual expenditure is almost 2,000 million …

MOUNTAIN VIEW, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug- …